The Canadian Institutes of Health Research and its partners, the Terry Fox Research Institute, the Canadian Cancer Society, the Japan Agency for Medical Research and Development, the Cancer Research Society and BioCanRx, are investing more than $41 million to support 19 research teams that will work over the next five years to develop and share new approaches that advance cancer prevention, reduce cancer risk, and improve early detection for some of the most commonly diagnosed cancers in Canada and the world.